Publications by authors named "Vikki Tang"

Claim this Profile
A
A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitors.
Hoi Wai Chan, Chris Chun Long Tse, Yu-Chung Li, Roland Leung, Gin Wai Kwok, Vikki Tang

Invest New Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.
Ka-On Lam, Karen Hoi-Lam Li, Roland Ching-Yu Leung, Vikki Tang, Thomas Yau

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
David Tak Wai Lui, Chi Ho Lee, Vikki Tang, Carol Ho Yi Fong, Alan Chun Hong Lee

Endocr Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Bryan Cho Wing Li, Joanne Chiu, Kit Shing, Gerry Gin Wai Kwok, Vikki Tang

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study.
Jeffrey Sum-Lung Wong, Yawen Dong, Vikki Tang, Thomas Leung, Cynthia S Y Yeung

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang, Bryan Cho Wing Li, Roland Leung

J Immunother Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy.
Joanne W Chiu, Roland Leung, Vikki Tang, Wai Yin Cheuk, Jessica Lo

Postgrad Med J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Thomas Yau, Vikki Y F Tang, Tzy-Jyun Yao, Sheung-Tat Fan, Chung-Mau Lo

Gastroenterology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis.
Joanne Chiu, Vikki Tang, Roland Leung, Hilda Wong, Kin Wah Chu

Asian Pac J Cancer Prev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
Hilda Wong, Kai P Wong, Thomas Yau, Vikki Tang, Roland Leung

Ann Surg Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis